These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 15898123)

  • 1. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
    Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
    Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
    Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
    Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
    Najim RA; Sharquie KE; Abu-Raghif AR
    J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
    Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
    Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability, late potentials and QT dispersion as markers of myocardial involvement in patients with Behçet's disease.
    Kirimli O; Aslan O; Göldeli O; Güneri S; Badak O; Fetil E; Ozkan S
    Can J Cardiol; 2000 Mar; 16(3):345-51. PubMed ID: 10744798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
    Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.